Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 700-704
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.700
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.700
Table 1 Base-line data of vaccinated and control patients (mean±SD).
| Vaccinated (n = 24, %) | Control (n = 26, %) | |
| Age (yr) | 53±9 | 49±15 |
| Male | 22 (92) | 21 (81) |
| Female | 2 (8) | 5 (19) |
| Cause of liver injury | ||
| Hepatitis B | 19 (79.1) | 18 (69.2) |
| Hepatitis C | 1 (4.2) | 2 (7.7) |
| Unknown | 4 (16.7) | 6 (23.1) |
| Child-Pugh class A | 23 (96) | 24 (92) |
| Child-Pugh class B | 1 (4) | 2 (8) |
| Alanine aminotransferase (U/L) | 75±35 | 50±95 |
| Cirrhosis | 16 (67) | 16 (62) |
| a-fetoprotein | ||
| ≥400 mg/L | 17 (71.3) | 16 (61.5) |
| <400 mg/L | 7 (28.7) | 10 (38.5) |
| Tumor size (major axis, mm) | 63±22 | 56±36 |
| AJCC stage I | 4 (17) | 2 (8) |
| AJCC stage II | 20 (83) | 24 (92) |
| Style of operation | ||
| Left lateral lobectomy | 3 | 4 |
| Left hepatectomy | 8 | 5 |
| Right hepatectomy | 2 | 3 |
| Irregular hepatectomy | 11 | 14 |
| Blood loss during operation (mL) | 812±536 | 769±620 |
| Blood transfusion during operation (mL) | 542±521 | 638±612 |
- Citation: Peng BG, Liang LJ, He Q, Kuang M, Lia JM, Lu MD, Huang JF. Tumor vaccine against recurrence of hepatocellular carcinoma. World J Gastroenterol 2005; 11(5): 700-704
- URL: https://www.wjgnet.com/1007-9327/full/v11/i5/700.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i5.700